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Background: Microglia are resident brain macrophages that can phagocytose dead, dying or viable neurons, which
may be beneficial or detrimental in inflammatory, ischaemic and neurodegenerative brain pathologies. Cell death
caused by phagocytosis of an otherwise viable cell is called ‘primary phagocytosis’ or ‘phagoptosis’. Calreticulin
(CRT) exposure on the surface of cancer cells can promote their phagocytosis via LRP (low-density lipoprotein
receptor-related protein) on macrophages, but it is not known whether this occurs with neurons and microglia.
Methods: We used primary cultures of cerebellar neurons, astrocytes and microglia to investigate the potential role
of CRT/LRP phagocytic signalling in the phagocytosis of viable neurons by microglia stimulated with
lipopolysaccharide (LPS) or nanomolar concentrations of amyloid-β peptide1-42 (Aβ). Exposure of CRT on the
neuronal surface was investigated using surface biotinylation and western blotting. A phagocytosis assay was also
developed using BV2 and PC12 cell lines to investigate CRT/LRP signalling in microglial phagocytosis of apoptotic
cells.
Results: We found that BV2 microglia readily phagocytosed apoptotic PC12 cells, but this was inhibited by a
CRT-blocking antibody or LRP-blocking protein (receptor-associated protein: RAP). Activation of primary rat
microglia with LPS or Aβ resulted in loss of co-cultured cerebellar granule neurons, and this was blocked by RAP or
antibodies against CRT or against LRP, preventing all neuronal loss and death. CRT was present on the surface of
viable neurons, and this exposure did not change in inflammatory conditions. CRT antibodies prevented
microglia-induced neuronal loss when added to neurons, while LRP antibodies prevented neuronal loss when
added to the microglia. Pre-binding of CRT to neurons promoted neuronal loss if activated microglia were added,
but pre-binding of CRT to microglia or both cell types prevented microglia-induced neuronal loss.
Conclusions: CRT exposure on the surface of viable or apoptotic neurons appears to be required for their
phagocytosis via LRP receptors on activated microglia, but free CRT can block microglial phagocytosis of neurons
by acting on microglia. Phagocytosis of CRT-exposing neurons by microglia can be a direct cause of neuronal death
during inflammation, and might therefore contribute to neurodegeneration and be prevented by blocking the CRT/
LRP pathway.
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Most neurological diseases involving neuronal loss are
accompanied by the appearance of activated microglia in
the affected tissues [1]. Microglia are resident brain ma-
crophages that mediate the immune response against
CNS infections and clear cellular debris following injury.
However, there is growing evidence that inflammatory-
activated microglia actively participate in the death of neu-
rons during neurodegenerative processes, for example
through release of reactive oxygen and nitrogen species
(ROS/RNS) and release of pro-inflammatory neurotoxic
cytokines and inflammatory mediators such as TNF-α [2].
We have recently described a novel form of neuronal
death mediated by inflammatory-activated microglia in
which microglia phagocytose viable neurons, referred to
as ‘primary phagocytosis’ or ‘phagoptosis’ [3,4]. Phagocy-
tosis is normally thought to occur after the target cell has
undergone cell death, but we found that in inflammatory
conditions inhibition of phagocytic signalling rescues neu-
rons both in vitro and in vivo, demonstrating that phago-
cytosis can be a direct cause of neuronal death in models
of inflammatory neurodegeneration [5-7].
Phagocytosis is controlled by a complex array of sig-
nals. The interaction between a number of ‘eat-me’ and
‘don’t-eat-me’ signals located on the target cell surface
and their respective receptors on the phagocyte deter-
mine whether or not phagocytosis takes place [8]. The
best-characterised ‘eat-me’ signal is exposure of the phos-
pholipid phosphatidylserine (PS) on the outer leaflet of
the plasma membrane. In most viable cells that are not
activated, PS is almost exclusively localised on the inner
leaflet of the plasma membrane due to an aminophospho-
lipid translocase that pumps PS from the outer to the
inner leaflet. Upon induction of cell death by apoptosis or
necrosis, PS becomes exposed on the cell surface due to
inactivation of the translocase or activation of a scram-
blase, which randomises phospholipid distribution bet-
ween the inner and outer leaflets thus resulting in net PS
exposure. However, PS exposure also occurs on the sur-
face of viable cells when ‘activated’, usually as a result of
calcium stimulation of the scramblase and inhibition of the
translocase, for example during activation of all leucocytes
[9-11], and on neurons exposed to oxidants from activated
microglia [5]. Exposed PS can be either bound directly by
some phagocyte receptors, such as Tim4, stabilin-1 and −2
and BAI1, or bound by bridging proteins such as MFG-E8,
which activates phagocytosis via the vitronectin receptor
(αvβ3/5 integrin) [8]. Indeed we have shown that primary
phagocytosis of viable neurons by inflammatory-activated
microglia is mediated by microglia-induced PS expo-
sure on viable neurons, evoking microglial phagocytosis
via MFG-E8 and the vitronectin receptor [5,7].
Surface-exposed calreticulin (CRT) has been demon-
strated to act as an eat-me signal in a number of celltypes [12]. CRT, principally characterized as an endo-
plasmic reticulum (ER)-resident chaperone, is constitu-
tively expressed at the surface of numerous cancer cell
lines and its expression at the cell surface can be in-
creased in the early stages of apoptosis induced by a
subset of apoptotic stimuli including anthracyclins and
UV irradiation [13,14]. CRT has been shown to act as an
essential eat-me signal promoting phagocytosis of apop-
totic cells and its activity can be modulated not only by
increasing exposure at the cell surface but also poten-
tially by rearrangement of existing exposed CRT [15,16].
Surface-exposed CRT is recognised by the phagocytic re-
ceptor LRP (low-density lipoprotein receptor-related
protein) [15,17], although CRT is also found associated
with LRP on the phagocyte membrane where it acts as a
co-receptor for LRP ligands such as C1q and alpha-2-
macroglobulin [18]. The constitutive expression of CRT
on the surface of a number of cell types does not neces-
sarily result in their phagocytosis as don’t-eat-me signals
have a dominant inhibitory effect on phagocytosis, for
example CD47 and its receptor SIRPα [13,15,19,20]. The
role and regulation of exposed CRT and LRP in media-
ting phagocytosis of neurons by microglia is unknown.
We therefore sought to test the requirement for CRT-
and LRP-mediated signalling for phagocytosis of dying
neurons and primary phagocytosis of viable neurons in
models of inflammatory neurodegeneration. Here we
demonstrate that neuronally exposed CRT is required as
an eat-me signal for phagocytosis of both apoptotic and
viable neurons by microglia, and that CRT is constitu-
tively exposed on the surface of neurons but this only
promotes phagocytosis in specific contexts, and indeed
released CRT can inhibit phagocytosis at microglia.
Methods
All experiments were performed in accordance with the
UK Animals (Scientific Procedures) Act (1986) and ap-
proved by the Cambridge University Local Research Ethics
Committee.
Cell culture and treatments
Mixed neuronal/glial cerebellar cultures were prepared
from the cerebella of postnatal day 5 to 7 rats as pre-
viously described [21] and were allowed to mature in vitro
for six to eight days prior to treatment. Pure microglia
were prepared from mixed cortical astroglial/microglial
cultures as previously described [5]. BV2 microglial cells
were grown in Dulbecco’s modified Eagle’s medium
(DMEM, Invitrogen, Carlsbad, CA, USA)) supplemented
with 10% fetal bovine serum (FBS, PAA Laboratories,
Colbe, Germany). PC12 neuronal cells were grown in
Roswell Park Memorial Institute medium (RPMI, Invitro-
gen) supplemented with 10% FBS and 20% horse serum
(Sigma-Aldrich, St Louis, MO, USA). PC12 were plated
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gen, Sigma-Aldrich). All tissue culture medium was sup-
plemented with 100 units/ml penicillin G, 100 μg/ml
streptomycin sulphate (Invitrogen). Reagents were pro-
cured as follows: lipopolysaccharide (LPS), calreticulin
(CRT), cytochalasin D (CytoD), 5-(and-6)-carboxytetra-
methylrhodamine succinimidyl ester (TAMRA) were from
Sigma-Aldrich. β 1–42 monomers (EZBiolab, Carmel,
IN, USA) were prepared as previously described [6].
Receptor-associated protein (RAP, R&D systems,
Minneapolis, MN, USA), normal mouse IgG (mIgG,
Santa Cruz Biotech, Santa Cruz, CA, USA), anti-CRT
antibodies (Abcam, Cambridge, UK; Stressgen, Brussels,
Belgium), anti-LRP (American Diagnostica Inc., Stamford,
CT, USA), Alexa 488-labelled isolectin B4 (IB4, Molecular
Probes, Eugene OR, USA). Neuronal and microglial cell
survival was quantified three days after stimulation as pre-
viously described [5]. Anti-CRT and anti-LRP blocking
antibodies were Fc-blocked with an F(ab’)2 fragment anti-
body (Jackson Immunoresearch, West Grove, PA, USA).
Nitrite levels in culture supernatants were measured as
previously described [5].
BV2 and PC12 phagocytosis assay
BV2 were plated in 6-well plates in DMEM plus 0.5%
FBS and were at approximately 60% confluency when
target cells were added. PC12 in suspension were stained
for 10 minutes with 50 μM TAMRA, washed in warm
PBS and then plated in 10 cm collagen-coated dishes at
high density. UV-treated PC12 received 200 mJ/cm2 ir-
radiation. Untreated and UV-treated PC12 were harvested
16 hours after UV treatment by trypsinisation. PC12 target
cells were counted and resuspended in DMEM plus 0.5%
FBS. Some 200,000 PC12 target cells were added to each
well of BV2 (approximate four-fold excess of target PC12
cells compared to BV2) followed by a two-hour incubation
at 37°C. For FACS analysis, BV2 were stained with IB4
(1 μg/ml) for 15 minutes prior to washing in PBS and brief
trypsinisation to detach cells. BV2 were then resuspended
in 200 μl PBS and FACS analysis performed using an
Accuri C6 Flow Cytometer (BD Services, San Jose, CA,
USA). Alexa 488 IB4 fluorescence was detected in FL1
channel whilst TAMRA fluorescence was detected in FL2.
For fluorescence microscopy, BV2 were labeled with IB4
as above and washed briefly in PBS prior to labelling of
nuclear DNA with Hoechst 33342 [5]. Cells were imaged
on an Olympus Fluoview 300 microscope (Olympus,
Tokyo, Japan).
Transwell and microglial reconstitution experiments
Following six to seven days in vitro microglia were se-
lectively eliminated from cerebellar cultures by adding
50 mM L-leucine methyl ester (LME, Sigma-Aldrich).
After three hours LME-containing medium was aspirated,neurons washed once in warm HBSS (Invitrogen) and
then medium was replaced with conditioned medium
from sister cultures. Twenty-four hours later, 6.5 mm
0.4 μm pore size polycarbonate transwell inserts (Corning,
Sigma-Aldrich) that had been poly-L-lysine coated were
inserted and 25,000 microglia were plated onto the insert.
After 24 hours, LPS was added at 100 ng/ml as indicated
in figure legends. Forty-eight hours later, transwell inserts
containing microglia were removed. During this time
microglia were purified and plated in 6-well plates, left for
24 hours and then incubated for a further 24 hours with
100 ng/ml LPS. LPS-activated pure microglia were gently
blown from wells after a brief incubation in Versene solu-
tion (Invitrogen) at 37°C. At this point, blocking antibody
was added to the neurons or to purified LPS-activated
microglia in suspension for one hour at 37°C. Neurons
were washed three times in warm HBSS before condi-
tioned medium from untreated sister cultures was added
back. LPS-activated microglia were washed three times in
warm HBSS, collected by centrifugation and counted. A
total of 25,000 LPS-activated microglia was then added
directly back to neuronal cultures as indicated and plates
were spun briefly to allow microglia to settle. Cerebellar
cultures were then incubated for six hours at 37°C before
neuronal survival and numbers were assessed as described
above. For addition of exogenous CRT, microglia were
eliminated from cerebellar granule cells (CGC) that had
been in vitro for seven days using LME as before. After
24 hours, 1 μg/ml CRT (Sigma-Aldrich) was added dir-
ectly to neurons and left to incubate for two hours, fol-
lowed by three washes in warm HBSS. Pure microglia that
had either been left untreated or LPS activated for
24 hours as described above were then added back to neu-
rons as indicated at a density of 25,000 cells per well
(24-well plate), plates incubated for six hours at 37°C
prior to quantification of neuronal number and survival.
Externalised protein biotinylation and pull-down
Surface biotinylation was performed using the Pierce Cell
Surface Protein Isolation Kit including Sulfo-NHS-SS-
Biotin as the labelling reagent (Thermo Fisher Scientific,
Waltham, MA, USA). Cerebellar cultures were seeded in
6-well plates and after six days in culture microglia were
eliminated with LME as described above. After 24 hours,
a poly-L-lysine-coated transwell was inserted and 200,000
purified microglia were plated on the transwell. Twenty-
four hours later, 100 ng/ml LPS was added where indi-
cated. After 48 hours, further incubation transwells were
removed and neuron plates were transferred to ice and
washed several times in HBSS prior to addition of Sulfo-
NHS-SS-Biotin. All subsequent steps including streptavi-
din pull-down of biotinylated proteins followed the manu-
facturer’s instructions. Neurons were lysed in a volume of
500 μl and prior to pull-down a load sample of 40 μl was
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beads were eluted by boiling in SDS gel loading buffer.
Proteins were separated by SDS-PAGE and transferred to
nitrocellulose membranes for western blot detection as
previously described [22].
Statistical analysis
Statistical analysis was performed using SPSS software.
All results represent the mean value from at least three
separate experiments (see figure legends) with each indi-
vidual experiment having two replicates per condition
with four fields counted per replicate. In figure legends
n = x refers to the number of separate experiments per-
formed. Error bars represent the standard error of the
mean of experiments (SEM). Normality of data was veri-
fied using the Shapiro-Wilk test. Data was analysed
using one-way ANOVA and post hoc Bonferroni test. In
figures * = P < 0.05, ** = P < 0.01, *** = P < 0.001.
Results
CRT/LRP signalling in phagocytosis of apoptotic PC12
cells by BV2 microglial cells
Cell-surface-exposed CRT has been demonstrated to
play an important role in mediating phagocytosis in vari-
ous cancer cell lines, either as an eat-me signal on the
target cell or as a co-receptor on the phagocytic cell sur-
face. Whether exposed CRT plays a role in phagocytosis
of neurons by microglia is unknown. Given the potential
importance of phagocytosis of neurons by microglia in
modulating neurodegenerative processes, we sought to
test whether phagocytosis of neurons by microglia
involved CRT-mediated signalling. In order to test the
role of CRT in phagocytosis of apoptotic neurons by
microglia, we established a phagocytosis assay using the
transformed microglial cell line, BV2, and the cell line
PC12 as target cells. BV2 cells were visualised with
Alexa 488-labelled isolectin B4 (IB4) whilst PC12 cells
were separately labelled with red fluorescent 5-(and-6)-
carboxytetramethylrhodamine succinimidyl ester (5(6)-
TAMRA) prior to treatment and addition to BV2. The
extent of phagocytosis was evaluated by determining the
proportion of BV2 cells that contained red fluorescence,
indicative of phagocytosis of the TAMRA-labelled target
cells. Initially, red fluorescence of BV2 was evaluated by
fluorescence microscopy and in later experiments FACS
analysis was employed (see figure legend for details)
(Figure 1A+B). Some experiments were performed
using both fluorescence microscopy and flow cytometry
for data collection, and flow cytometry was more sensi-
tive to low levels of TAMRA staining within the BV2
cells, so that a higher level of labelled BV2 cells was seen
by flow cytometry. However, the trends seen when
phagocytic inhibitors were added were similar and statis-
tically significant with both methods (data not shown).As expected very little phagocytosis occurred when live
PC12 were added to BV2 (5.9% ± 0.5%, Figure 1C),
but this greatly increased when apoptotic PC12 were
added (45.3% ± 0.5%, Figure 1C). Cytochalasin D, a
well-characterised inhibitor of phagocytosis, significantly
inhibited the phagocytosis of apoptotic cells by BV2, de-
monstrating that phagocytosis of target cells was
required for TAMRA uptake by BV2 (Figure 1C). We
tested the requirement for cell surface CRT and LRP
for phagocytosis of apoptotic cells by microglia using a
CRT-blocking antibody [19] and recombinant RAP, a
LRP-binding protein, which inhibits ligand binding by
LRP [23]. Addition of a CRT-blocking antibody to PC12
cells prior to washing and then addition to BV2 was suffi-
cient to significantly reduce phagocytosis of apoptotic
PC12 cells by BV2 (live PC12, 1% ± 0.3%; apoptotic
PC12, 11.5% ± 0.3%; apoptotic PC12 +CRT blocking,
4.3% ± 0.5%; Figure 1D). RAP significantly inhibited
phagocytosis of apoptotic PC12 when incubated with
BV2 prior to addition of target cells but not when incu-
bated with apoptotic PC12 cells prior to addition to BV2
(live PC12, 6.7%± 3.7%; apoptotic PC12, 52%±3.1%; apo-
ptotic PC12+RAP microglia, 33.2%± 2.4%; apoptotic
PC12+RAP neuron, 52.7%±1.4%; Figure 1E). Thus
phagocytosis of apoptotic PC12 by the microglial cell line
BV2 requires recognition of CRT on the target cell mem-
brane and ligand binding by LRP on the microglia.
CRT/LRP signalling in primary phagocytosis of viable
cerebellar granule neurons by microglia activated by LPS
or Aβ
Tumour cell lines and transformed cells frequently expose
the eat-me signal CRT at the cell surface and consequently
CRT plays a pivotal role in determining whether or not
these cells are phagocytosed [13]. Less is known about the
role of CRT in phagocytosis of primary cells, including
neurons. We recently demonstrated that in addition to
clearance of apoptotic and necrotic debris, in certain cir-
cumstances inflammatory-activated microglia may actively
participate in neurodegenerative processes by phagocytos-
ing viable neurons both in vitro and in vivo [5,7].
Inflammatory-activated microglia produce ROS/RNS that
induce reversible exposure of PS on the neuronal sur-
face, at which point microglia phagocytose the viable PS-
exposing neurons resulting in neuronal death by ‘primary
phagocytosis’ [5]. A defining feature of primary phagocyt-
osis as a form of cell death is that inhibition of any of the
critical components of the phagocytic signalling machin-
ery is sufficient to rescue neurons, both in vitro and
in vivo.
We tested the role of CRT and LRP in primary phago-
cytosis using the TLR4 ligand LPS as an inflammatory
stimulus. LPS has been well characterised by us and
others as a means of inducing microglial activation in
Figure 1 Phagocytosis of apoptotic neurons by microglia requires LRP/CRT signalling. (A) Example of flow cytometer phagocytosis assay
data. Points represent individual cells with on the X axis staining for Alexa 488 IB4 (bound to BV2 cells only) and on the Y axis staining for TAMRA
(bound to PC12 cells only). Co-staining (above the line) indicates BV2 phagocytosis of PC12s, which is increased when PC12s are apoptotic (right).
(B) Fluorescent microscopy images of BV2 cells labelled with IB4 (green) showing BV2 that have phagocytosed TAMRA-labelled target cells (white
hollow arrows) and unphagocytosed TAMRA-labelled target cells attached to BV2 cell surface (white solid arrow). DNA stained with Hoechst
33342 is shown in blue. (C) Cytochalasin D inhibits phagocytosis of apoptotic TAMRA-labelled PC12 by BV2 (flow data). (D) 10 μg/ml CRT-
blocking antibody inhibits phagocytosis of apoptotic PC12 by BV2 (microscopy data). (E) Addition of 250 nM RAP to BV2 inhibits phagocytosis,
but not when added to the apoptotic target PC12 cells (flow data). (C), (D) and (E) represent mean value from three separate experiments with
two replicates per experiment. Error bars represent SEM. CRT, calreticulin; IB4, isolectin B4; LRP, low-density lipoprotein receptor-related protein;
RAP, receptor-associated protein; TAMRA, 5-(and-6)-carboxytetramethylrhodamine succinimidyl ester.
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viously reported [5], 72 hours of LPS treatment resulted
in the disappearance of a portion of healthy neurons
without any concurrent appearance of dead neurons
(Figure 2A). LPS-induced neuronal death was entirely
dependent on the presence of microglia in the culture
(data not shown and [5]). Addition of a CRT-blockingantibody was sufficient to prevent neuronal death, with-
out blocking microglial activation (as indicated by
increased nitrite production in the presence of LPS and
microglial proliferation) (Figure 2A+B and data not
shown). Similarly, the LRP-blocking protein RAP signifi-
cantly inhibited LPS-induced neuronal death without
affecting microglial nitrite production (Figure 2C+D).
Figure 2 Disruption of CRT/LRP phagocytic signalling inhibits primary phagocytosis induced by LPS or Aβ. (A, C + E) Co-cultures of
cerebellar neurons and glia were treated with 100 ng/ml LPS for 72 hours in the presence of 1 μg/ml CRT-blocking antibody (A), 250 nM RAP (C)
or 1 μg/ml LRP-blocking antibody (E). In (A) and (E) normal mouse IgG (mIgG) was added to control for non-specific effects of CRT- and LRP-
blocking antibodies. In (C) and (I) ‘control’ refers to addition of PBS alone as RAP was dissolved in PBS prior to addition. Neuronal survival was
quantified using Hoechst/PI staining after 72 hours. (B, D+ F) Production of nitrite as a measure of microglial activation was measured in cell
culture supernatants from experiments shown in (A) (B), (C) (D) and (E) (F). (G-J) Cerebellar co-cultures were treated with 250 nM Aβ peptide for
72 hours in the presence of CRT-blocking antibody (G+H) or RAP (I + J) prior to quantification of neuronal survival (G+ I) and microglial density
(H+ J). All data represent the mean value of three separate experiments (two replicates per experiment). Error bars represent SEM. Aβ, amyloid-β
peptide1-42; CRT, calreticulin; LPS, lipopolysaccharide; LRP, low-density lipoprotein receptor-related protein; RAP, receptor-associated protein.
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almost complete rescue from LPS-induced neuronal death
and had no effect on microglial activation as measured by
nitrite production (Figure 2E+ F). Isotype-matched IgG
controls had no effect on LPS-induced neuronal loss and
microglial activation (2A, B, E + F).
We recently reported that nanomolar concentrations
of amyloid-beta (Aβ) peptide that were not directly
neurotoxic were able to induce primary phagocytosis of
neurons by microglia in a PS-dependent manner [6]. Of
note, Aβ-induced primary phagocytosis is not accompan-
ied by the usual markers of microglial activation such as
nitrite production, TNF-α release and microglial prolifera-
tion, potentially reflective of a M2-type microglial phe-
notype [25]. We tested whether CRT/LRP phagocytic
signalling may also be required for Aβ-induced primary
phagocytosis using the CRT-blocking antibody and RAP.
As expected, Aβ induced a significant loss of neurons
after 72 hours treatment, without increasing the number
of apoptotic or necrotic neurons (Figure 2G-J). However,
addition of either CRT-blocking antibodies or LRP-
blocking RAP was able to prevent Aβ-induced primary
phagocytosis and rescue viable neurons (Figure 2G-J). In
sum, inhibition of the CRT/LRP phagocytic machinery
was sufficient to prevent primary phagocytosis of neurons
by microglia induced by either LPS or Aβ.
CRT acts as an ‘eat-me-if’ signal on neurons
The above data indicated that CRT/LRP were necessary
for primary phagocytosis of cerebellar granule neurons
by microglia to occur. As discussed above, two roles for
surface-exposed CRT have been described, one as aneat-me signal on the target cell surface, acting as a bin-
ding ligand for LRP on the phagocytic cell (described as
trans) and a second role with CRT acting as a co-
receptor with LRP for other ligands including comple-
ment component C1q (cis) on the phagocyte membrane
[15,18]. We sought to test the site of actions of both
CRT and LRP blocking agents and thus establish
whether CRT/LRP were operating in trans or cis during
primary phagocytosis. We previously demonstrated that
microglia placed in a transwell were able to release
ROS/RNS upon activation and induce reversible PS flip
of viable neurons, although physical contact was required
for primary phagocytosis to proceed [5]. These ‘primed’
PS-exposing neurons were then rapidly phagocytosed
when activated microglia were added back directly to the
neurons. We used this model to test whether blocking
agents would prevent primary phagocytosis if added to
primed neurons or if added to activated microglia prior to
mixing of the two cell types (Figure 3A for schematic).
Following addition of blocking agents, both neurons and
microglia were washed to remove excess unbound block-
ing agent before microglia were added back to the primed
neurons. The LRP-blocking antibody prevented primary
phagocytosis when added to microglia but not when
added to primed neurons, consistent with LRP being re-
quired on the microglial/phagocyte surface (Figure 3B).
Microglial counts showed that similar amounts of acti-
vated microglia were added back to primed neuronal cul-
tures in all conditions (data not shown). In contrast to the
LRP-blocking antibody, the CRT-blocking antibody dis-
played a significant neuroprotective effect when added di-
rectly to primed neurons and no protective effect when
Figure 3 LRP blocking agents act on microglia and CRT blocking inhibits neuronal sites to prevent primary phagocytosis. (A) Schematic
showing experimental design for microglial elimination/reconstitution/inhibition studies. (B) 1 μg/ml LRP-blocking antibody inhibits LPS-induced
primary phagocytosis of PS-exposing ‘primed’ neurons when antibody added to microglia but not when incubated with neuronal targets prior to
readdition of microglia (excess antibody was washed off cells prior to addition of microglia to neurons). Microglia were added to primed
neuronal cultures for six hours followed by quantification of neuronal survival. (C) 1 μg/ml CRT-blocking antibody inhibits LPS-induced primary
phagocytosis when pre-incubated with primed neurons but not when pre-incubated with microglia. (B) and (C), data represent three separate
experiments with two replicates per experiment. mIgG=mouse IgG control. Error bars represent SEM. CRT, calreticulin; LPS, lipopolysaccharide;
LRP, low-density lipoprotein receptor-related protein; PS, phosphatidylserine.
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that CRT/LRP are required and operate in trans for pri-
mary phagocytosis to proceed.
Our data indicated that CRT exposure on the neuronal
cell surface was required for primary phagocytosis to
proceed. We next tested whether exposed CRT alone
was sufficient to allow primary phagocytosis to occur.
Several other groups have shown that addition of ex-
ogenous CRT to cells is sufficient to allow or enhance
phagocytosis of target cells. Intriguingly addition of ex-
ogenous CRT to LPS-treated CGC cultures resulted in a
significant inhibition of primary phagocytosis, rather
than an enhancement as hypothesised (Figure 4A).Inflammatory activation of microglia as measured by ni-
trite production was not affected by exogenous CRT
(Figure 4B). Addition of exogenous CRT also inhibited
Aβ-induced primary phagocytosis (Figure 4C+D). We
tested whether the inhibitory effect of exogenous CRT
was mediated by an action on the neuronal target cells or
on the microglia using the method described in Figure 3A.
When exogenous CRT was added to primed neurons
prior to readdition of activated microglia there was a slight
increase in primary phagocytosis, although this did not
reach statistical significance (Figure 4E). However, incuba-
tion of exogenous CRT with the activated microglia prior
to adding them back to the primed neurons significantly
Figure 4 Exogenous CRT mediates a dominant inhibitory effect on primary phagocytosis by acting on microglia. (A+B) Co-cultures of
cerebellar neurons and glia were incubated with LPS for 72 hours in the presence or absence of 2 μg/ml exogenous CRT prior to quantification
of neuronal survival (A) and microglial activation as measured by nitrite levels in culture supernatant at 72 hour timepoint (B). (C +D) Co-cultures
were incubated with Aβ peptide for 72 hours in the presence or absence of exogenous CRT prior to quantification of neuronal survival (C) and
microglial density (D). (E) Exogenous CRT inhibits LPS-induced primary phagocytosis when pre-incubated with microglia but not with primed
neurons. CRT was added to either neurons or microglia separately, washed out and then microglia were added to neurons for six hours prior to
quantification of neuronal survival (E). (F) Co-cultures were treated with LME to remove microglia prior to addition of exogenous CRT where
indicated. Pure microglia, either unactivated or LPS-activated, were then added back to neurons for six hours prior to quantification of neuronal
survival. (A-E) Data represent three experiments with two replicates per experiment. (F) Data represent six experiments with two replicates per
experiment. All error bars represent SEM. Aβ, amyloid-β peptide1-42; CRT, calreticulin; LME, L-leucine methyl ester; LPS, lipopolysaccharide.
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nous CRT exerted a dominant inhibitory effect on primary
phagocytosis when added to microglia.
To test whether surface CRT was sufficient to induce
phagocytosis of unprimed neurons we eliminated micro-
glia from CGC with LME, incubated neurons with ex-
ogenous CRT, washed off any excess unbound CRT and
then added back microglia that were either unactivated
or LPS-activated. Addition of exogenous CRT to neu-
rons followed by unactivated microglia did not result
in any significant change in numbers of healthy or
dead neurons. In contrast, when LPS-activated micro-
glia were added back to neurons that had been incubated
with exogenous CRT a significant loss of neurons was ob-
served (unprimed neurons +LPS microglia, 87.4%±2.9%;
unprimed neurons+ exogenous CRT+LPS microglia,
65.9%± 4.5%; Figure 4F). Thus addition of exogenous CRT
to unprimed neurons alone was not sufficient to allow pri-
mary phagocytosis, except when microglia had been
inflammatory-activated with LPS.
We previously demonstrated that inflammatory-activa-
ted microglia release ROS/RNS which induce a reversible
exposure of PS on the surface of viable neurons [5]. To
test whether CRT was exposed in a similar manner to PS,
we performed a surface biotinylation of ‘unprimed’ or
‘primed’ neurons (see Figure 3A) and compared levels
of biotinylated (that is, externalised) CRT between the
two populations. As expected, beta-tubulin was not
biotinylated indicating that intracellular proteins were
not biotinylated (Figure 5A). In contrast, CRT was biotiny-
lated in both unprimed and primed neuronal cultures,
and the amount of biotinylated CRT pulled down did not
differ between unprimed and primed neurons. WeFigure 5 Constitutive exposure of CRT at the neuronal surface is not
primed neurons (see Figure 1A) reveals that CRT is externalised to equal ex
induces PS flip on viable neurons, does not alter surface expression of CRTpreviously found that treatment with sub-lethal doses of
peroxynitrite could induce reversible PS flip on viable
neurons but this treatment also had no effect on surface
CRT levels on the neurons (Figure 5B). In sum, neurons
appeared to expose a constant amount of CRT even in the
presence of stimuli that had previously been shown to in-
duce PS flip and allow primary phagocytosis to proceed.Discussion
In this study we demonstrate that the CRT/LRP system is
required for primary phagocytosis of viable neurons by
microglia, so that inhibition of this system could prevent
neuronal loss and death induced by LPS or Aβ. Given the
increasing evidence supporting a neurodegenerative role
for microglia, this system might potentially play a role in
loss of neurons during inflammatory neurodegenerative
processes such as brain infections (for example, AIDS de-
mentia), ischaemia (for example, stroke), inflammation
(for example, multiple sclerosis), trauma or neurodege-
neration (for example, Alzheimer’s or Parkinson’s disease)
[3,26]. However, this requires further investigation in rele-
vant models of disease. We found that RAP can prevent
neuronal loss induced by LPS or Aβ, and thus in principal
might be therapeutically useful, at least in acute, life-
threatening brain pathologies such as stroke, trauma or
meningitis. RAP is normally expressed in the brain but
declines in Alzheimer’s disease [27], which might in
principle contribute to the neuronal loss.
We have previously shown that microglia activated by
LPS or Aβ induce neuronal loss and death by phago-
cytosis of otherwise viable neurons, and this ‘primary
phagocytosis’ required microglia-induced PS exposuremodulated during priming of neurons. (A) Surface biotinylation of
tent on both primed and unprimed neurons. (B) Peroxynitrite, which
on neurons. CRT, calreticulin; PS, phosphatidylserine.
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cytosis of the neurons via microglial vitronectin recep-
tors [5-7]. PS exposure on viable neurons was induced
by peroxynitrite production by microglia and phagocyt-
osis of neurons occurred independently of apoptosis
[5,7]. In the present work, we have found that the CRT/
LRP pathway plays a permissive role for this induced
primary phagocytosis, such that if the CRT/LRP pathway
is blocked primary phagocytosis can not proceed. The
finding that blocking this phagocytic pathway with CRT
antibodies, LRP antibodies, RAP or free CRT results in
the accumulation of live rather than dead neurons, again
supports the notion that the neurons are lost by primary
phagocytosis, rather than phagocytosis secondary to the
neurons dying by some other means.
We also found that CRT/LRP was important for BV2
microglial phagocytosis of apoptotic PC12 cells. If this is
true for primary neurons and microglia in vivo, then
blocking this system may be detrimental in a variety of
physiological and pathological conditions by allowing
dead neurons to accumulate and promote inflammation.
However, for cancer cells, it has been shown that macro-
phage phagocytosis of CRT-exposed cancer cells is im-
munogenic as the macrophages present antigens from
these cells [14]. This immunogenic phagocytosis of CRT
exposing dead cells might be beneficial in the context of
brain tumours or brain infections, but potentially detri-
mental in other contexts such as MS or development. It
is possible that the CRT/LRP system contributes to the
phagocytosis apoptotic and viable neurons arising during
development. In C.elegans mutation of a number of the
Ced genes (including Ced1, a proposed functional ho-
mologue of LRP) involved in phagocytosis of dead cells in
combination with a weak Ced3 (caspase) mutation results
in survival of cells normally eliminated in the presence of
the weak Ced3 mutation alone [28,29]. CRT knockout is
lethal in mice, and intriguingly 16% of CRT-null mice de-
velop exencephaly of the brain characterised by failure to
close the neural tube, a process involving programmed cell
death [30,31].Figure 6 Schematic representing requirements for primary phagocyto
does not proceed without microglial activation. Basal levels of surface-expo
dependent phagocytosis can be triggered by an increase in either PS or CROur data are consistent with a model in which CRT
acts as an eat-me signal on the neuronal surface and is
recognised by LRP on the phagocytic membrane, as has
been described in other non-neuronal systems [15,17].
LRP is known to be expressed and functional on microglia
[32]. Through use of surface biotinylation, we demon-
strated that CRT is constitutively expressed on the surface
of cerebellar neurons. A previous report from Hossain and
colleagues demonstrated external localisation of CRT on
rat hippocampal neurons where it co-localised with
NMDA receptor and potentially played a role in modulat-
ing Ca2+ influx into neurons [33]. The amount of CRT was
unchanged when neurons were primed for phagocytosis by
inflammatory-activated microglia. Studies in non-neuronal
cell types have shown that CRT-dependent phagocyt-
osis does not necessarily require increased CRT exposure.
In some cell types surface-exposed CRT accumulates in
patches on the cell surface, often in association with
exposed PS [15,16,34]. CRT-dependent phagocytosis can
also be triggered by a reduction in don’t-eat-me signalling
by CD47/SIRPα signalling [13,15,19]. However, we tested
a CD47-blocking antibody and found that this had no ef-
fect on phagocytosis of viable or apoptotic neuronal cells
in the presence or absence of inflammatory stimuli
(data not shown). Gardai and colleagues demonstrated
that CRT knockout prevented phagocytosis of PS-
exposing apoptotic cells, and that readdition of exogenous
CRT restored phagocytosis although this phagocytosis
remained PS-dependent [15]. Similarly, in our model we
have shown that LPS-activated microglia induce PS expos-
ure on viable neurons and that PS recognition by MFG-E8
is required for phagocytosis to proceed [5,7]. Thus whilst
CRT is not increased on the surface of viable neurons dur-
ing primary phagocytosis, the exposure of PS induced by
LPS-activated microglia may be sufficient to allow phago-
cytosis that occurs in a CRT-dependent manner. We
demonstrated that incubation of viable neurons with ex-
ogenous CRT allowed primary phagocytosis to proceed in
the presence of activated but not unactivated microglia. It
is possible that other types of neuropathologically relevantsis of neurons to proceed. Primary phagocytosis of viable neurons
sed CRT are not sufficient alone to allow phagocytosis, but CRT-
T exposure. CRT, calreticulin; PS, phosphatidylserine.
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therefore, may cause neurodegeneration by primary
phagocytosis in this way.
We found that addition of CRT to microglia or to both
microglia and neurons could block microglia-induced
neuronal loss. This may be because free CRT can acti-
vate microglial phagocytosis/endocytosis via LRP in the
absence of bound neurons/target cells (as occurs in
macrophages [15]), resulting in downregulation of sur-
face LRP and associated phagocytic machinery. This type
of mechanism might be involved in the neuroprotective
effect of peptide Y-P30. Y-P30 can bind CRT and was
reported to cause release of extracellular CRT in SH-
SY5Y cells, as well as dissociation of CRT from mem-
branes isolated from rat cortex. In conjunction with this
activity, Y-P30 inhibited the appearance of microglia
in vivo following lesioning of the cortex in rat [35].
Conclusions
CRT exposure on the surface of viable or apoptotic neu-
rons is required for their phagocytosis via LRP receptors
on microglia. CRT is exposed on neurons in the pre-
sence or absence of inflammation, and appears to be
permissive for PS-induced phagocytosis. Based on our
present and previous data, we propose that CRT acts as
an ‘eat-me-if ’ signal as illustrated in Figure 6. Phagocy-
tosis of neurons by microglia normally requires: i) CRT
exposure on neurons, AND ii) PS exposure on neurons,
AND iii) activation of microglia. However, high levels of
CRT exposure on neurons can override the requirement
for PS exposure, and free CRT can block phagocytosis of
neurons by acting directly on microglia.
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